Abstract:Antidepressants are among the most commonly detected pharmaceuticals in aqueous systems, and, as emerging organic pollutants, may exert negative effects on non-target aquatic organisms. Previously, it has been revealed that antidepressant exposure significantly inhibits the growth and development of fish during their early developmental stages. Thus, in the present study, we aimed to identify and compare the underlying mechanisms of action of different antidepressants at the transcriptional level using zebrafish (Danio rerio) embryos. Through high-throughput RNA sequencing (RNA-Seq) data analysis, 32, 34, and 130 differentially expressed genes (DEGs) were obtained from zebrafish larvae after 120h of embryonic exposure to sublethal concentrations of amitriptyline, fluoxetine, and mianserin, respectively. The expression profiles of the identified DEGs showed similar trends in response to the three antidepressant treatments, suggesting consistent toxic effects of low concentrations of these three drugs on the regulation of gene expression in fish. Several metabolic and signaling pathways, including glycolysis/gluconeogenesis and the insulin pathway, were affected in the exposed fish larvae. The expression profiles of selected DEGs were then verified by the qRT-PCR method, which indicated significant positive correlations with the RNA-Seq results. Next, we determined the concentration-dependent expression patterns of 6 selected DEGs in fish larvae exposed to three antidepressants at a series of environmentally relevant concentrations. The results revealed a significant concentration-dependent reduction in the levels of dual-specificity phosphatase 5 (dusp5) mRNA, as well as a non-concentration-dependent gene expression inhibition of prostaglandin D2 synthase b (ptgdsb); the circadian rhythm-related genes, i.e. those encoding nuclear receptor subfamily 1, group D, member 1 (nr1d1) and period 2 (per2); and genes encoding early growth response factors (egr1 and egr4), in the antidepressant-treated fish larvae. In summary, to our knowledge, our findings demonstrate, for the first time, that the three different categories of antidepressants have common effects on the gene expression involved in multiple biological processes and signaling pathways during the early development of fish and thus provide information for characterizing the adverse outcome pathways and on the ecological risk assessment of these pharmaceutical pollutants in the aquatic environment.

Environmentally Relevant Concentrations of Sertraline Disrupts Behavior and the Brain and Liver Transcriptome of Juvenile Yellow Catfish (tachysurus Fulvidraco): Implications for the Feeding and Growth Axis.

Molecular and behavioral responses of zebrafish embryos/larvae after sertraline exposure.

Molecular and Behavioral Responses of Zebrafish Embryos/larvae after Sertraline Exposure

The antidepressant, sertraline, impacts growth and reproduction in the benthic deposit feeder, Tubifex tubifex

Molecular, behavioral, and growth responses of juvenile yellow catfish (Tachysurus fulvidraco) exposed to carbamazepine

Antidepressant sertraline impairs the induced morphological defense of <i>Ceriodaphnia cornuta</i> in response to <i>Chaoborus</i> larvae kairomone

Low doses and lifecycle exposure of waterborne antidepressants in zebrafish model: A survey on sperm traits, reproductive behaviours, and transcriptome responses

Transcriptome networks and physiology related to cardiac function and motor activity are perturbed in larval zebrafish (Danio rerio) following exposure to the antidepressant citalopram

Differential effects of antidepressant sertraline in glochidia-fish interactions involving drug transfer from parasite to host

Early Environmental Exposure to Oxytetracycline in Danio Rerio May Contribute to Neurobehavioral Abnormalities in Adult Zebrafish.

Long-Term Exposure to SSRI Citalopram Induces Neurotoxic Effects in Zebrafish

Toxicity of waterborne vortioxetine, a new antidepressant, in non-target aquatic organisms: From wonder to concern drugs?

Global Transcriptomic Analysis of Zebrafish in Response to Embryonic Exposure to Three Antidepressants, Amitriptyline, Fluoxetine and Mianserin.

Waterborne pharmaceutical uptake and toxicity is modified by pH and dissolved organic carbon in zebrafish

Parental exposure to antidepressants has lasting effects on offspring? A case study with zebrafish

Environmental level of the antidepressant venlafaxine induces behavioral disorders through cortisol in zebrafish larvae (Danio rerio)

Transcriptional analyses reveal different mechanism of toxicity for a chronic exposure to fluoxetine and venlafaxine on the brain of the marine fish Dicentrarchrus labrax

Integrated physio-biochemical and transcriptomic analysis reveals the joint toxicity mechanisms of two typical antidepressants fluoxetine and sertraline on Microcystis aeruginosa

The potential for adverse effects in fish exposed to antidepressants in the aquatic environment

Fluoxetine modulates the transcription of genes involved in serotonin, dopamine and adrenergic signalling in zebrafish embryos

Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM)